Northern Trust Corp Accelerate Diagnostics, Inc Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.64 - $1.03 $640 - $1,030	-1,000 Reduced 0.67%	148,865 $120,000
Q1 2023 May 15, 2023	BUY	$0.46 - $0.77 $26,837 - $44,924	58,343 Added 63.75%	149,865 $104,000
Q4 2022 Feb 13, 2023	BUY	$0.51 - $17.1 $4,446 - $149,094	8,719 Added 10.53%	91,522 $64,000
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $267 - $4,505	265 Added 0.32%	82,803 $126,000
Q2 2022 Aug 12, 2022	SELL	$0.54 - $1.41 $145,257 - $379,282	-268,995 Reduced 76.52%	82,538 $82,000
Q1 2022 May 13, 2022	SELL	$1.4 - $5.15 $101,722 - $374,193	-72,659 Reduced 17.13%	351,533 $506,000
Q4 2021 Feb 08, 2022	BUY	$4.27 - $6.97 $50,898 - $83,082	11,920 Added 2.89%	424,192 $2.21 Million
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $192,142 - $298,526	36,185 Added 9.62%	412,272 $2.4 Million
Q2 2021 Aug 13, 2021	SELL	$6.81 - $9.23 $37,598 - $50,958	-5,521 Reduced 1.45%	376,087 $3.03 Million
Q1 2021 May 12, 2021	SELL	$7.99 - $15.0 $191,016 - $358,605	-23,907 Reduced 5.9%	381,608 $3.18 Million
Q4 2020 Feb 11, 2021	BUY	$7.04 - $11.7 $28,680 - $47,665	4,074 Added 1.01%	405,515 $3.07 Million
Q3 2020 Nov 16, 2020	BUY	$9.98 - $18.04 $301,545 - $545,078	30,215 Added 8.14%	401,441 $4.28 Million
Q2 2020 Aug 14, 2020	SELL	$7.49 - $15.16 $79,686 - $161,287	-10,639 Reduced 2.79%	371,226 $5.63 Million
Q1 2020 May 14, 2020	SELL	$4.62 - $18.74 $4,291 - $17,409	-929 Reduced 0.24%	381,865 $3.18 Million
Q4 2019 Feb 14, 2020	SELL	$14.6 - $18.13 $42,091 - $52,268	-2,883 Reduced 0.75%	382,794 $6.47 Million
Q3 2019 Nov 13, 2019	BUY	$16.62 - $23.92 $372,337 - $535,879	22,403 Added 6.17%	385,677 $7.16 Million
Q2 2019 Aug 13, 2019	BUY	$17.79 - $22.88 $73,650 - $94,723	4,140 Added 1.15%	363,274 $8.31 Million
Q1 2019 May 13, 2019	BUY	$11.76 - $22.15 $54,589 - $102,820	4,642 Added 1.31%	359,134 $7.55 Million
Q4 2018 Feb 12, 2019	SELL	$10.42 - $21.94 $74,388 - $156,629	-7,139 Reduced 1.97%	354,492 $4.08 Million
Q3 2018 Nov 14, 2018	BUY	$20.4 - $24.6 $220,768 - $266,221	10,822 Added 3.08%	361,631 $8.3 Million
Q2 2018 Sep 18, 2018	SELL	$19.02 - $24.95 $82,470 - $108,183	-4,336 Reduced 1.22%	350,809 $7.82 Million
Q2 2018 Aug 14, 2018	BUY	$19.02 - $24.95 $246,194 - $322,952	12,944 Added 3.78%	355,145 $7.92 Million
Q1 2018 May 09, 2018	BUY	$22.55 - $29.9 $209,218 - $277,412	9,278 Added 2.79%	342,201 $7.82 Million
Q4 2017 Feb 14, 2018	SELL	$18.0 - $30.0 $165,942 - $276,570	-9,219 Reduced 2.69%	332,923 $8.72 Million
Q3 2017 Nov 13, 2017	BUY	$21.1 - $25.15 $7.22 Million - $8.6 Million	342,142	342,142 $7.68 Million

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account